A federal appeals court has ruled that abortion drug mifepristone can remain available, but has blocked the drug from being sent to patients in the mail, along with other
Democrats in the House of Representatives will introduce a bill today that seeks to reaffirm the authority of the FDA on drug approvals, after a Texas court held that the
Eisai has reached an agreement with Japan’s National Cancer Centre to run a trial of its EZH2 inhibitor Tazverik in young people with cancers who either have no drug treatment availab